ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 110 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,214,651 | -17.9% | 1,583,572 | -7.0% | 0.00% | 0.0% |
| Q2 2023 | $3,915,019 | +77702.4% | 1,702,182 | +2.5% | 0.00% | -33.3% |
| Q1 2023 | $5,032 | +16.6% | 1,660,566 | -10.4% | 0.00% | +50.0% |
| Q4 2022 | $4,317 | -99.9% | 1,852,715 | -47.2% | 0.00% | -50.0% |
| Q3 2022 | $6,704,000 | -40.5% | 3,510,188 | -15.6% | 0.00% | -42.9% |
| Q2 2022 | $11,271,000 | +87.6% | 4,159,064 | +106.3% | 0.01% | +133.3% |
| Q1 2022 | $6,009,000 | -49.2% | 2,016,324 | -33.7% | 0.00% | -50.0% |
| Q4 2021 | $11,822,000 | +135.2% | 3,039,185 | +159.4% | 0.01% | +100.0% |
| Q3 2021 | $5,027,000 | +188.6% | 1,171,695 | +123.9% | 0.00% | +200.0% |
| Q1 2021 | $1,742,000 | +171.3% | 523,263 | +189.2% | 0.00% | – |
| Q4 2020 | $642,000 | +58.5% | 180,962 | -18.7% | 0.00% | -100.0% |
| Q2 2020 | $405,000 | -52.7% | 222,573 | -73.7% | 0.00% | -50.0% |
| Q1 2020 | $856,000 | +4.0% | 847,164 | +186.2% | 0.00% | +100.0% |
| Q4 2019 | $823,000 | +51.6% | 295,976 | -16.9% | 0.00% | 0.0% |
| Q3 2019 | $543,000 | -49.9% | 356,066 | -31.7% | 0.00% | -50.0% |
| Q2 2019 | $1,084,000 | +271.2% | 521,025 | +1584.9% | 0.00% | – |
| Q3 2018 | $292,000 | -54.1% | 30,924 | -64.5% | 0.00% | -100.0% |
| Q2 2018 | $636,000 | +863.6% | 87,089 | +559.4% | 0.00% | – |
| Q1 2018 | $66,000 | -84.1% | 13,207 | -83.9% | 0.00% | -100.0% |
| Q4 2017 | $414,000 | +233.9% | 82,007 | +309.1% | 0.00% | – |
| Q3 2017 | $124,000 | -16.8% | 20,046 | -56.2% | 0.00% | – |
| Q1 2017 | $149,000 | +217.0% | 45,818 | +138.6% | 0.00% | – |
| Q4 2016 | $47,000 | -97.1% | 19,204 | -96.0% | 0.00% | -100.0% |
| Q3 2016 | $1,638,000 | -19.7% | 476,122 | -18.8% | 0.00% | -40.0% |
| Q2 2016 | $2,040,000 | -38.1% | 586,076 | -26.5% | 0.01% | -37.5% |
| Q1 2016 | $3,295,000 | -38.5% | 797,740 | -33.8% | 0.01% | -27.3% |
| Q4 2015 | $5,360,000 | -35.1% | 1,204,445 | -11.2% | 0.01% | -31.2% |
| Q3 2015 | $8,257,000 | – | 1,355,839 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |